newsfilter
← Latest News
GlobeNewswire·

Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business Highlights

– Significant progress in Comera's ongoing research collaboration with Regeneron, a leading U.S. biotechnology company – – Further development of Comera's pipeline candidate CLS-001 (SQ vedolizumab), highlighted by